Drug intelligence / Profile preview

fluorescein sodium + benoxinate hydrochloride

Development stage
Unknown
Lead developer
Bausch & Lomb
Modality
Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Ophthalmic
01

Overview

Fluorescein sodium + benoxinate hydrochloride is a fixed-dose combination ophthalmic solution used primarily for diagnostic and minor therapeutic procedures in the eye. It combines fluorescein sodium, a disclosing (staining) agent that highlights corneal defects or foreign bodies under blue light, with benoxinate hydrochloride, a local ester anesthetic that provides rapid-onset but short-duration topical anesthesia. This combination facilitates procedures such as tonometry, gonioscopy, removal of corneal foreign bodies, and fitting of hard contact lenses by both staining the ocular surface and numbing the eye to reduce discomfort[1][2][3][4][5]. The product is available in various strengths (commonly 0.25–0.3% fluorescein sodium with 0.4% benoxinate hydrochloride)[1][2][6]. Prolonged use may cause corneal toxicity; it is contraindicated in patients with hypersensitivity to any component[4].

Brand names
FluressFluroxAltafluor Benox
Other names
fluorescein sodium and benoxinate hydrochloride ophthalmic solutionfluorescein sodium / benoxinate HCl
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on fluorescein sodium + benoxinate hydrochloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluorescein sodium + benoxinate hydrochloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call